pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 20·1 min read
save

Medicare proposes cuts to hospital payments for drugs and imaging under new outpatient rule

Jul 20, 2026·read at STAT ↗RegulatoryNegative

Medicare's Centers for Medicare & Medicaid Services released a proposed rule that would lower the amounts hospitals receive for certain prescription drugs and imaging services provided to Medicare beneficiaries.

The proposal targets the 340B drug discount program, reducing the discounts hospitals can claim, which the agency says will save federal spending but is expected to strain hospital finances.

The rule also reinforces a site‑neutral payment approach that many hospitals have opposed, as it could further erode revenue from outpatient services.

Stakeholders have submitted tens of thousands of comments, reflecting strong opposition from the hospital industry and concerns about patient access.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The next step of site-neutral, and a fiery PBM hearing”

read at STAT ↗
509 words · retrieved Jul 20
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
PainSmall Molecule

related stories

  • 16h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Aug 18Leo Pharma buys rare skin disease drug in $435M dealBioPharma Dive
  • Aug 18LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drugBioSpace
  • Aug 18Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposureEndpoints
  • Aug 17Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nodFierce Biotech